Erschienen in:
12.11.2019 | Concise Research Report
Research Waste in Randomized Clinical Trials: a Cross-Sectional Analysis
verfasst von:
Alexander R Zheutlin, Joshua Niforatos, Eric Stulberg, Jeremy Sussman
Erschienen in:
Journal of General Internal Medicine
|
Ausgabe 10/2020
Einloggen, um Zugang zu erhalten
Excerpt
Randomized clinical trials (RCT) require substantial investments from patients, investigators, and funding agencies. RCTs that fail to be completed or to report findings represent research waste, and unnecessary patient harm. Determining RCT viability is critical in allocating funds, and
ClinicalTrials.gov provides a platform for investigators to post results from completed RCTs irrespective of “success,” which can influence publication.
1 We sought to describe research waste in Phase 3 RCTs as indicated by inability to reach completion and insufficient reporting of results when completed. …